Mid-treatment changes in intra-tumoural metabolic heterogeneity correlate to outcomes in oropharyngeal squamous cell carcinoma patients
Mid-treatment changes in intra-tumoural FDG-PET/CT heterogeneity correlated with treatment outcomes in OPSCC and may help with response prediction. These findings suggest potential utility in designing future risk adaptive clinical trials.
Authors
- Paul Keall (ORCID: https://orcid.org/0000-0003-4803-6507)
- Michael Jameson (ORCID: https://orcid.org/0000-0003-4867-7670)
- Allan Fowler (ORCID: https://orcid.org/0000-0003-1061-5511)
- Yuvnik Trada (ORCID: https://orcid.org/0000-0001-7935-6904)
- Mark Lee (ORCID: https://orcid.org/0000-0003-4866-4116)
- Phillip Chlap (ORCID: https://orcid.org/0000-0002-6517-8745)
- Peter Lin
- D. Moses (ORCID: https://orcid.org/0009-0000-6252-2662)
Institutions
- The University of Sydney (AU)
- Liverpool Hospital (AU)
- UNSW Sydney (AU)
- Australian and New Zealand Intensive Care Society (AU)
- Prince of Wales Hospital (AU)
- St Vincent's Clinic (AU)
- Ingham Institute (AU)
- Calvary Mater Newcastle Hospital (AU)
- Western Sydney University (AU)
Publication Details
- Journal
- EJNMMI Research
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1186/s13550-025-01226-6
- Primary Topic
- Radiomics and Machine Learning in Medical Imaging
- Type
- article
- Field-Weighted Citation Impact
- 0.00